Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy (NCT06658145) | Clinical Trial Compass
RecruitingNot Applicable
Safety and Efficacy of Using a Novel Full Visual Access Platform System in Transvaginal Hysterectomy
China94 participantsStarted 2025-02
Plain-language summary
The modified vNOTES hysterectomy was accomplished and validated for efficacy and safety using a multi-access vaginal confinement instrument with a fully visualised vaginal access platform.
Who can participate
Age range60 Years
SexFEMALE
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion criteria
✓. Female patients ≤ 60years old
✓. Patients requiring total hysterectomy (with or without bilateral adjuncts or salpingectomy) due to uterine fibroids
✓. BMI ranges from 18.5 to 27.9kg/m2;
✓. Informed consent signed by the subject himself or his legal representative.
Exclusion criteria
✕. Pregnant and lactating women;
✕. asexual life history, vaginal malformations or adhesions, postmenopausal vaginal atrophy and stenosis;
✕. Preoperative examination for malignant possibility
✕. Uterine volume ≥20 weeks, history of pelvic inflammatory disease, severe endometriosis, degree III or IV uterine prolapse; Previous surgical history of intestinal obstruction, recurrent pelvic inflammatory disease, pelvic tuberculosis, and pelvic abdominal tumor; Gynecological examination of the uterine and rectal fossa is completely closed;
✕. Patients known to have severe hepatic or renal dysfunction;
✕. Patients with known blood disorders, coagulation disorders, active bleeding at any site, or bleeding propensity;
✕. complicated with serious diseases of central nervous system, cardiovascular system, liver and kidney, digestive tract, respiratory system, endocrine and metabolism (thyroid disease, Cushing\'s syndrome, hyperprolactinemia), skeletal and muscular system and mental disorders;